SELEGILINE HYDROCHLORIDE

SELEGILINE HYDROCHLORIDE was reported 589 times

SELEGILINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OESOPHAGEAL SQUAMOUS CELL CARCINOMA RECURRENT 1 0.0833
1 DELUSIONAL DISORDER, JEALOUS TYPE 1 0.0714
2 SYMPATHICOTONIA 1 0.0667
3 CATECHOLAMINES URINE 1 0.0625
4 DYSKINESIA HYPERPYREXIA SYNDROME 2 0.0426
5 MEIGE'S SYNDROME 1 0.0270
6 SCROTAL HAEMATOCOELE 2 0.0241
7 PHOSPHENES 1 0.0238
8 TACITURNITY 2 0.0227
9 DRUG RECHALLENGE POSITIVE 1 0.0222
10 WHITE BLOOD CELL MORPHOLOGY ABNORMAL 1 0.0222
11 GASTRIC ULCER HELICOBACTER 2 0.0211
12 MEDICAL DEVICE SITE ULCER 1 0.0208
13 MANUFACTURING PRODUCTION ISSUE 2 0.0192
14 ENDOCARDIAL FIBROSIS 1 0.0189
15 RENAL HAMARTOMA 1 0.0179
16 MOROSE 3 0.0175
17 MEDICAL DEVICE SITE CELLULITIS 1 0.0172
18 EXCESSIVE SEXUAL FANTASIES 1 0.0167
19 PANIC DISORDER WITH AGORAPHOBIA 1 0.0167
20 WHITE BLOOD CELL ANALYSIS ABNORMAL 1 0.0161
21 TOXIC INDUCED ENCEPHALOPATHY 2 0.0160
22 EARLY RETIREMENT 1 0.0149
23 CAMPTOCORMIA 3 0.0125
24 PARKINSONISM HYPERPYREXIA SYNDROME 2 0.0112
25 SPINAL MENINGEAL CYST 1 0.0106
26 ADMINISTRATION SITE INFECTION 1 0.0105
27 CAROTID ARTERY ATHEROMA 1 0.0094
28 GASTRITIS ATROPHIC 1 0.0066
29 DEEP BRAIN STIMULATION 4 0.0066
30 CATHETER SITE WARMTH 1 0.0061
31 ENCEPHALITIS BRAIN STEM 1 0.0058
32 PATIENT ELOPEMENT 2 0.0055
33 PARKINSONIAN REST TREMOR 1 0.0053
34 POSTOPERATIVE DELIRIUM 1 0.0051
35 CORTISOL ABNORMAL 1 0.0050
36 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 2 0.0050
37 PROGRESSIVE SUPRANUCLEAR PALSY 1 0.0050
38 EXCESSIVE MASTURBATION 1 0.0048
39 STOMA SITE OEDEMA 1 0.0046
40 PRODUCT DOSAGE FORM ISSUE 2 0.0041
41 DYSLALIA 3 0.0041
42 NECROTISING OESOPHAGITIS 2 0.0040
43 SPINAL INSTABILITY 1 0.0039
44 CSF PRESSURE INCREASED 1 0.0038
45 VESTIBULAR NEURONITIS 2 0.0037
46 MARITAL PROBLEM 2 0.0037
47 LABILE HYPERTENSION 1 0.0036
48 INSPIRATORY CAPACITY DECREASED 1 0.0036
49 MEDICAL DEVICE SITE PAIN 2 0.0036
50 INTRACRANIAL HAEMATOMA 2 0.0036
51 PARKINSON'S DISEASE 9 0.0035
52 PSYCHOSEXUAL DISORDER 1 0.0035
53 IMPULSE-CONTROL DISORDER 7 0.0034
54 HYPNAGOGIC HALLUCINATION 1 0.0033
55 PRODUCT APPEARANCE CONFUSION 3 0.0032
56 CAUSTIC INJURY 1 0.0032
57 URINE AMPHETAMINE POSITIVE 1 0.0030
58 PHAEOCHROMOCYTOMA 2 0.0030
59 HYPERCREATINAEMIA 1 0.0030
60 INGUINAL HERNIA REPAIR 1 0.0030
61 HEAT ILLNESS 2 0.0030
62 DRUG THERAPY 1 0.0029
63 SUDDEN ONSET OF SLEEP 4 0.0029
64 HYPERKINESIA 6 0.0028
65 STOMA SITE INFLAMMATION 2 0.0027
66 HYPOGLYCAEMIC ENCEPHALOPATHY 1 0.0026
67 DROPPED HEAD SYNDROME 1 0.0025
68 BRONCHITIS ACUTE 1 0.0025
69 EXCESSIVE GRANULATION TISSUE 2 0.0025
70 MASKED FACIES 1 0.0025
71 SLEEP TALKING 4 0.0024
72 CAROTID ARTERY DISSECTION 1 0.0023
73 TONIC CLONIC MOVEMENTS 3 0.0023
74 MOUTH BREATHING 1 0.0023
75 PLEUROTHOTONUS 2 0.0022
76 HYPERSEXUALITY 4 0.0022
77 INJURY ASPHYXIATION 1 0.0022
78 POSTURE ABNORMAL 7 0.0021
79 HYPERTENSIVE HEART DISEASE 4 0.0021
80 BASEDOW'S DISEASE 1 0.0021
81 STEREOTYPY 2 0.0021
82 SLEEP ATTACKS 1 0.0021
83 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
84 STOMA SITE PAIN 3 0.0020
85 INFUSION SITE ABSCESS 1 0.0020
86 LIBIDO INCREASED 4 0.0020
87 PHYSIOTHERAPY 1 0.0019
88 ORTHOPAEDIC PROCEDURE 1 0.0019
89 FLIGHT OF IDEAS 1 0.0019
90 BLOOD ALBUMIN ABNORMAL 1 0.0019
91 INFUSION SITE CELLULITIS 1 0.0019
92 PRODUCT COMMINGLING 2 0.0019
93 INFUSION SITE MASS 2 0.0018
94 PATHOLOGICAL GAMBLING 3 0.0018
95 ON AND OFF PHENOMENON 10 0.0018
96 CHOREA 3 0.0017
97 GAMBLING 2 0.0017
98 SUTURE INSERTION 1 0.0017
99 SENSE OF OPPRESSION 2 0.0017
100 SPINAL EPIDURAL HAEMATOMA 1 0.0017
101 BRADYKINESIA 10 0.0017
102 HALLUCINATIONS, MIXED 7 0.0017
103 PERSECUTORY DELUSION 4 0.0016
104 PARKINSONIAN GAIT 1 0.0016
105 BLOOD OSMOLARITY DECREASED 1 0.0016
106 STOMA SITE HYPERGRANULATION 1 0.0016
107 GASTRIC ULCER PERFORATION 2 0.0016
108 RESTING TREMOR 1 0.0015
109 REFLEXES ABNORMAL 1 0.0015
110 SPINAL CORD INFECTION 1 0.0015
111 COUNTERFEIT PRODUCT ADMINISTERED 2 0.0015
112 EMBOLIC CEREBRAL INFARCTION 1 0.0015
113 HAND DERMATITIS 1 0.0014
114 STOMA CREATION 1 0.0014
115 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
116 DELUSION 22 0.0014
117 PUBIS FRACTURE 1 0.0014
118 CEREBELLAR HAEMORRHAGE 2 0.0014
119 CALCULUS URETERIC 1 0.0014
120 GASTRIC MUCOSAL LESION 1 0.0014
121 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
122 INFUSION SITE INDURATION 2 0.0013
123 AMPHETAMINES POSITIVE 1 0.0013
124 HALLUCINATION, VISUAL 28 0.0013
125 LABORATORY TEST INTERFERENCE 1 0.0013
126 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 1 0.0013
127 FEAR OF FALLING 1 0.0012
128 POST PROCEDURAL HAEMATOMA 2 0.0012
129 PERIORBITAL PAIN 1 0.0012
130 SOLILOQUY 1 0.0012
131 THALAMUS HAEMORRHAGE 1 0.0011
132 IMMOBILE 5 0.0011
133 FOOD REFUSAL 1 0.0011
134 INFUSION SITE DISCOLOURATION 1 0.0011
135 CEREBELLAR ATROPHY 1 0.0011
136 EXTENSOR PLANTAR RESPONSE 1 0.0011
137 ABULIA 1 0.0011
138 CATHETER SITE SWELLING 1 0.0011
139 SLEEP-RELATED EATING DISORDER 1 0.0011
140 HYPERMETROPIA 1 0.0011
141 DUODENAL ULCER HAEMORRHAGE 3 0.0010
142 RADIOTHERAPY 2 0.0010
143 INFUSION SITE NODULE 1 0.0010
144 DISCOLOURED VOMIT 1 0.0010
145 DYSKINESIA 42 0.0010
146 BLADDER CATHETERISATION 1 0.0010
147 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
148 AUTONOMIC NEUROPATHY 1 0.0010
149 REDUCED FACIAL EXPRESSION 1 0.0010
150 HYPERPYREXIA 4 0.0009
151 BINGE EATING 1 0.0009
152 STREPTOCOCCAL BACTERAEMIA 1 0.0009
153 MUSCLE RIGIDITY 11 0.0009
154 DISTRACTIBILITY 1 0.0009
155 HYPERTENSIVE EMERGENCY 1 0.0008
156 HALLUCINATION 63 0.0008
157 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
158 SLOW SPEECH 2 0.0008
159 MONOCYTE COUNT DECREASED 1 0.0008
160 PANCREATIC NEOPLASM 1 0.0008
161 REHABILITATION THERAPY 3 0.0008
162 SLOW RESPONSE TO STIMULI 1 0.0008
163 OESOPHAGEAL HAEMORRHAGE 1 0.0008
164 CYSTITIS NONINFECTIVE 1 0.0007
165 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
166 AGORAPHOBIA 1 0.0007
167 STOMA SITE DISCHARGE 2 0.0007
168 BEZOAR 1 0.0007
169 DRUG SCREEN FALSE POSITIVE 2 0.0007
170 CHRONIC FATIGUE SYNDROME 1 0.0007
171 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
172 TONIC CONVULSION 1 0.0007
173 AORTIC VALVE INCOMPETENCE 3 0.0007
174 BLOOD ELECTROLYTES DECREASED 1 0.0007
175 INTENSIVE CARE 1 0.0007
176 HYPOGLYCAEMIC COMA 2 0.0007
177 HYPERTONIC BLADDER 2 0.0007
178 VISUAL FIELD DEFECT 5 0.0007
179 FAT TISSUE INCREASED 1 0.0007
180 MUTISM 1 0.0007
181 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
182 JUDGEMENT IMPAIRED 1 0.0007
183 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
184 GENERALISED ANXIETY DISORDER 1 0.0007
185 PNEUMONIA PNEUMOCOCCAL 1 0.0007
186 APRAXIA 1 0.0007
187 MOUTH INJURY 1 0.0007
188 MARASMUS 1 0.0007
189 PARANOIA 11 0.0006
190 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
191 INAPPROPRIATE AFFECT 1 0.0006
192 DISINHIBITION 1 0.0006
193 INTESTINAL POLYP 1 0.0006
194 COLONIC POLYP 1 0.0006
195 TROPONIN I INCREASED 1 0.0006
196 POTENTIATING DRUG INTERACTION 2 0.0006
197 PRODUCT COLOUR ISSUE 3 0.0006
198 WOUND COMPLICATION 2 0.0006
199 TONGUE COATED 1 0.0006
200 INFUSION SITE DISCHARGE 1 0.0006
201 DUODENAL ULCER 4 0.0006
202 AORTIC VALVE STENOSIS 1 0.0006
203 VOCAL CORD PARALYSIS 1 0.0006
204 NONSPECIFIC REACTION 3 0.0005
205 SINUS NODE DYSFUNCTION 1 0.0005
206 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
207 PNEUMONIA KLEBSIELLA 1 0.0005
208 DISORGANISED SPEECH 1 0.0005
209 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
210 STOMA SITE ERYTHEMA 1 0.0005
211 IMPATIENCE 1 0.0005
212 MYELOPATHY 1 0.0005
213 CARDIAC VALVE DISEASE 3 0.0005
214 PNEUMONIA ASPIRATION 13 0.0005
215 ORTHOSTATIC HYPOTENSION 9 0.0005
216 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
217 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
218 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
219 HALLUCINATION, AUDITORY 8 0.0005
220 CEREBRAL ATROPHY 2 0.0005
221 HYPERPHAGIA 2 0.0005
222 EYELID PAIN 1 0.0005
223 DELIRIUM 17 0.0005
224 COMPULSIVE SHOPPING 1 0.0005
225 SPINAL COMPRESSION FRACTURE 4 0.0005
226 CHEST INJURY 1 0.0005
227 AKINESIA 1 0.0005
228 HEMIPLEGIA 4 0.0005
229 CONGESTIVE CARDIOMYOPATHY 2 0.0005
230 SLEEP TERROR 2 0.0005
231 THERAPEUTIC RESPONSE CHANGED 3 0.0005
232 INCONTINENCE 5 0.0005
233 SEROTONIN SYNDROME 9 0.0005
234 CATHETER SITE ERYTHEMA 1 0.0005
235 EXOPHTHALMOS 1 0.0005
236 JAW FRACTURE 1 0.0005
237 INFUSION SITE BRUISING 1 0.0005
238 HAEMORRHAGIC ANAEMIA 2 0.0005
239 SOPOR 6 0.0005
240 WHEELCHAIR USER 2 0.0004
241 PARESIS 1 0.0004
242 SPINAL COLUMN INJURY 1 0.0004
243 BACTERIAL TEST POSITIVE 1 0.0004
244 PSEUDOMEMBRANOUS COLITIS 1 0.0004
245 ADENOCARCINOMA 1 0.0004
246 FEAR OF DEATH 1 0.0004
247 MITRAL VALVE INCOMPETENCE 5 0.0004
248 BRAIN OPERATION 1 0.0004
249 HYPERTRANSAMINASAEMIA 3 0.0004
250 INFUSION SITE INFECTION 1 0.0004
251 PATELLA FRACTURE 1 0.0004
252 ORAL SURGERY 1 0.0004
253 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
254 EOSINOPHIL COUNT DECREASED 1 0.0004
255 HYPOKINESIA 6 0.0004
256 PARKINSONISM 4 0.0004
257 CATHETER SITE HAEMORRHAGE 1 0.0004
258 METASTASES TO PERITONEUM 1 0.0004
259 URINARY TRACT INFECTION BACTERIAL 1 0.0004
260 LABYRINTHITIS 1 0.0004
261 DYSPHORIA 2 0.0004
262 TOXIC ENCEPHALOPATHY 2 0.0004
263 HAEMORRHAGE URINARY TRACT 1 0.0004
264 PHYSICAL DECONDITIONING 1 0.0004
265 DRUG TITRATION ERROR 1 0.0004
266 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
267 HERNIA REPAIR 1 0.0004
268 CATATONIA 2 0.0004
269 LUNG OPACITY 1 0.0004
270 YAWNING 1 0.0004
271 SHOULDER ARTHROPLASTY 1 0.0004
272 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
273 DECUBITUS ULCER 3 0.0004
274 CLONUS 1 0.0004
275 GASTRIC ULCER HAEMORRHAGE 2 0.0004
276 STREPTOCOCCAL INFECTION 2 0.0004
277 LUNG CONSOLIDATION 1 0.0004
278 HYPERTONIA 2 0.0003
279 HEART VALVE INCOMPETENCE 1 0.0003
280 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
281 ENTEROCOLITIS 2 0.0003
282 LUMBAR SPINAL STENOSIS 1 0.0003
283 STRIDOR 1 0.0003
284 INFUSION SITE REACTION 1 0.0003
285 BLOOD CULTURE POSITIVE 1 0.0003
286 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
287 CENTRAL VENOUS CATHETERISATION 1 0.0003
288 CRANIOCEREBRAL INJURY 1 0.0003
289 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
290 EYE INJURY 1 0.0003
291 INGUINAL HERNIA 2 0.0003
292 MASTICATION DISORDER 1 0.0003
293 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
294 UROSEPSIS 3 0.0003
295 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
296 PIGMENTATION DISORDER 2 0.0003
297 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
298 DRUG EFFECT INCREASED 1 0.0003
299 AFFECT LABILITY 3 0.0003
300 LOOSE TOOTH 1 0.0003
301 DYSTONIA 6 0.0003
302 BODY TEMPERATURE DECREASED 3 0.0003
303 LISTLESS 1 0.0003
304 WALKING AID USER 2 0.0003
305 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
306 PRODUCT LABEL ISSUE 2 0.0003
307 SUBARACHNOID HAEMORRHAGE 3 0.0003
308 TACHYPHRENIA 1 0.0003
309 HYPERREFLEXIA 1 0.0003
310 APPLICATION SITE REACTION 2 0.0003
311 LOGORRHOEA 1 0.0003
312 DEPRESSIVE SYMPTOM 1 0.0003
313 FACIAL BONES FRACTURE 1 0.0003
314 DEVICE KINK 1 0.0003
315 INTENTIONAL UNDERDOSE 2 0.0003
316 FREEZING PHENOMENON 1 0.0003
317 HYPERTENSIVE CRISIS 3 0.0003
318 FEELING DRUNK 2 0.0003
319 PROTEIN TOTAL DECREASED 1 0.0003
320 GASTRIC ULCER 5 0.0003
321 HYPERTHERMIA 2 0.0003
322 COMMUNICATION DISORDER 1 0.0003
323 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
324 PANIC DISORDER 1 0.0003
325 RHINOVIRUS INFECTION 1 0.0003
326 OESOPHAGEAL PAIN 1 0.0003
327 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
328 MYOCLONUS 3 0.0003
329 BLOOD PRESSURE FLUCTUATION 6 0.0002
330 INTRACRANIAL ANEURYSM 1 0.0002
331 APPLICATION SITE DISCOLOURATION 1 0.0002
332 RESTLESSNESS 9 0.0002
333 AGITATION 18 0.0002
334 CARDIOMEGALY 3 0.0002
335 SELF-MEDICATION 1 0.0002
336 RIB FRACTURE 5 0.0002
337 DRUG INTERACTION 38 0.0002
338 PSYCHOTIC DISORDER 7 0.0002
339 PRODUCT COMPLAINT 6 0.0002
340 CARDIAC FAILURE CHRONIC 1 0.0002
341 ABNORMAL SENSATION IN EYE 1 0.0002
342 MONOPLEGIA 1 0.0002
343 BEDRIDDEN 3 0.0002
344 DYSPHEMIA 1 0.0002
345 ONYCHOMYCOSIS 1 0.0002
346 ILEUS PARALYTIC 1 0.0002
347 CHROMATURIA 5 0.0002
348 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
349 MOVEMENT DISORDER 7 0.0002
350 GRAND MAL CONVULSION 2 0.0002
351 INTERCEPTED MEDICATION ERROR 1 0.0002
352 RENAL FUNCTION TEST ABNORMAL 1 0.0002
353 THINKING ABNORMAL 4 0.0002
354 SPEECH DISORDER 11 0.0002
355 MEDICATION RESIDUE PRESENT 1 0.0002
356 APHAGIA 1 0.0002
357 DIZZINESS POSTURAL 2 0.0002
358 CHOKING 4 0.0002
359 HOSPICE CARE 2 0.0002
360 ABNORMAL BEHAVIOUR 8 0.0002
361 INFLAMMATORY MARKER INCREASED 1 0.0002
362 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
363 ANEURYSM 1 0.0002
364 HYPERAMMONAEMIA 1 0.0002
365 ECONOMIC PROBLEM 3 0.0002
366 SLUGGISHNESS 2 0.0002
367 INITIAL INSOMNIA 2 0.0002
368 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
369 STOMACH DISCOMFORT 1 0.0002
370 EJECTION FRACTION DECREASED 3 0.0002
371 ACCIDENTAL OVERDOSE 7 0.0002
372 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
373 SUDDEN DEATH 2 0.0002
374 BRADYCARDIA 10 0.0002
375 PRODUCT RESIDUE PRESENT 1 0.0002
376 PRODUCT DISPENSING ERROR 4 0.0002
377 ABNORMAL DREAMS 5 0.0002
378 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
379 HAEMOPTYSIS 5 0.0002
380 ANGIOPATHY 1 0.0002
381 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
382 PERIORBITAL SWELLING 1 0.0002
383 IMPAIRED DRIVING ABILITY 2 0.0002
384 SHOCK 4 0.0002
385 BALANCE DISORDER 15 0.0002
386 MULTI-ORGAN FAILURE 3 0.0002
387 SKIN WARM 1 0.0002
388 COGNITIVE DISORDER 8 0.0002
389 CATARACT OPERATION 1 0.0002
390 MACULAR DEGENERATION 2 0.0002
391 WRIST FRACTURE 2 0.0002
392 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
393 DERMATITIS ACNEIFORM 1 0.0002
394 DRUG DIVERSION 1 0.0002
395 CHOLANGITIS 1 0.0002
396 PRE-EXISTING CONDITION IMPROVED 1 0.0002
397 DYSARTHRIA 6 0.0002
398 BLEPHAROSPASM 1 0.0002
399 SLEEP APNOEA SYNDROME 3 0.0002
400 MYDRIASIS 2 0.0002
401 HIP FRACTURE 5 0.0002
402 INFUSION SITE PAIN 2 0.0002
403 INCOHERENT 1 0.0002
404 APPLICATION SITE VESICLES 1 0.0002
405 HEPATITIS ACUTE 1 0.0002
406 SOMNAMBULISM 1 0.0002
407 DYSGRAPHIA 1 0.0002
408 APPETITE DISORDER 1 0.0002
409 TREMOR 25 0.0002
410 PRESCRIBED UNDERDOSE 3 0.0002
411 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
412 POST-TRAUMATIC STRESS DISORDER 1 0.0001
413 PRODUCT ADMINISTRATION ERROR 3 0.0001
414 BRONCHIECTASIS 1 0.0001
415 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
416 FALL 49 0.0001
417 GAIT DISTURBANCE 28 0.0001
418 NEPHROTIC SYNDROME 1 0.0001
419 HAIR GROWTH ABNORMAL 1 0.0001
420 KNEE ARTHROPLASTY 3 0.0001
421 HAND FRACTURE 1 0.0001
422 THERMAL BURN 1 0.0001
423 EATING DISORDER 3 0.0001
424 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
425 FEAR OF INJECTION 1 0.0001
426 AGGRESSION 7 0.0001
427 MYELODYSPLASTIC SYNDROME 2 0.0001
428 MENTAL DISORDER 6 0.0001
429 CONFUSIONAL STATE 22 0.0001
430 BLINDNESS TRANSIENT 1 0.0001
431 PSYCHIATRIC SYMPTOM 1 0.0001
432 HAEMORRHAGE INTRACRANIAL 2 0.0001
433 GENERAL SYMPTOM 1 0.0001
434 BLOOD POTASSIUM DECREASED 4 0.0001
435 DRUG DISPENSING ERROR 2 0.0001
436 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
437 APNOEA 1 0.0001
438 PELVIC FRACTURE 1 0.0001
439 THERAPY PARTIAL RESPONDER 2 0.0001
440 DEHYDRATION 17 0.0001
441 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
442 BLOOD ALBUMIN DECREASED 1 0.0001
443 TRICUSPID VALVE INCOMPETENCE 1 0.0001
444 MOBILITY DECREASED 9 0.0001
445 LOSS OF CONSCIOUSNESS 16 0.0001
446 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
447 CARDIAC FAILURE 10 0.0001
448 HYPERHIDROSIS 16 0.0001
449 RHINITIS 1 0.0001
450 MYASTHENIA GRAVIS 1 0.0001
451 HYPOGLYCAEMIA 6 0.0001
452 ABNORMAL FAECES 1 0.0001
453 HICCUPS 1 0.0001
454 MANIA 2 0.0001
455 ABASIA 3 0.0001
456 DRUG LEVEL INCREASED 2 0.0001
457 ACUTE CORONARY SYNDROME 1 0.0001
458 URINARY RETENTION 4 0.0001
459 BLOOD UREA INCREASED 2 0.0001
460 ATRIAL SEPTAL DEFECT 1 0.0001
461 INFUSION SITE ERYTHEMA 1 0.0001
462 FACIAL PARALYSIS 1 0.0001
463 MUSCULOSKELETAL DISCOMFORT 2 0.0001
464 MUSCLE STRAIN 1 0.0001
465 URINE OUTPUT DECREASED 1 0.0001
466 MUSCULOSKELETAL STIFFNESS 10 0.0001
467 BLOOD CALCIUM INCREASED 1 0.0001
468 LUNG INFILTRATION 1 0.0001
469 WRONG DRUG ADMINISTERED 1 0.0001
470 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
471 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
472 ANAL INCONTINENCE 1 0.0001
473 OSTEOMYELITIS 2 0.0001
474 CRYING 4 0.0001
475 RESTLESS LEGS SYNDROME 2 0.0001
476 IRON DEFICIENCY ANAEMIA 1 0.0001
477 DEMENTIA 3 0.0001
478 LACERATION 1 0.0001
479 FRACTURE 2 0.0001
480 SPUTUM DISCOLOURED 1 0.0001
481 BLOOD PRESSURE DECREASED 7 0.0001
482 INTERSTITIAL LUNG DISEASE 5 0.0001
483 VITAMIN D DEFICIENCY 1 0.0001
484 RENAL TUBULAR NECROSIS 1 0.0001
485 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
486 VITREOUS FLOATERS 1 0.0001
487 THERAPY CHANGE 1 0.0001
488 KNEE OPERATION 1 0.0001
489 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
490 DISORIENTATION 4 0.0001
491 BLADDER DISORDER 1 0.0001
492 UPPER LIMB FRACTURE 2 0.0001
493 HYPOTHERMIA 1 0.0001
494 MOTOR DYSFUNCTION 1 0.0001
495 EUPHORIC MOOD 1 0.0001
496 HELICOBACTER INFECTION 1 0.0001
497 HYPERBILIRUBINAEMIA 1 0.0001
498 VENTRICULAR EXTRASYSTOLES 1 0.0001
499 EYE DISCHARGE 1 0.0001
500 RESPIRATORY FAILURE 7 0.0001
501 RHABDOMYOLYSIS 4 0.0001
502 INTENTIONAL DRUG MISUSE 2 0.0001
503 ROAD TRAFFIC ACCIDENT 4 0.0001
504 TRANSFUSION 1 0.0001
505 HEAD INJURY 3 0.0001
506 SOMNOLENCE 19 0.0001
507 ATRIAL FIBRILLATION 9 0.0001
508 PULMONARY THROMBOSIS 1 0.0001
509 OESOPHAGITIS 1 0.0001
510 ASPIRATION 1 0.0001
511 MELAENA 2 0.0001
512 TOOTH FRACTURE 1 0.0001
513 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
514 LIVER DISORDER 4 0.0001
515 OCULAR DISCOMFORT 1 0.0001
516 APPLICATION SITE PRURITUS 2 0.0001
517 DEPRESSION 20 0.0001
518 MYOCARDIAL ISCHAEMIA 1 0.0001
519 DERMATITIS CONTACT 1 0.0001
520 SUICIDAL IDEATION 8 0.0001
521 CONSTIPATION 19 0.0001
522 METASTASES TO LUNG 1 0.0001
523 HYPERKALAEMIA 3 0.0001
524 HEART RATE DECREASED 3 0.0001
525 SPINAL PAIN 1 0.0001
526 DYSPHAGIA 8 0.0001
527 ATAXIA 1 0.0001
528 MENTAL IMPAIRMENT 2 0.0001
529 SUICIDE ATTEMPT 5 0.0001
530 PANIC ATTACK 3 0.0001
531 SCHIZOPHRENIA 1 0.0001
532 PRESYNCOPE 2 0.0001
533 NO THERAPEUTIC RESPONSE 1 0.0001
534 CEREBRAL INFARCTION 2 0.0001
535 DYSURIA 3 0.0001
536 LIVER INJURY 2 0.0001
537 SPINAL OPERATION 1 0.0001
538 GENERALISED OEDEMA 1 0.0001
539 ILEUS 1 0.0001
540 HEPATIC FUNCTION ABNORMAL 3 0.0001
541 SYNCOPE 8 0.0001
542 SECRETION DISCHARGE 1 0.0001
543 DRUG WITHDRAWAL SYNDROME 7 0.0001
544 CELLULITIS 4 0.0001
545 CONDITION AGGRAVATED 24 0.0001
546 HYPOPHAGIA 2 0.0001
547 ERECTILE DYSFUNCTION 2 0.0001
548 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
549 APPLICATION SITE ERYTHEMA 2 0.0001
550 PULMONARY CONGESTION 1 0.0001
551 DYSMENORRHOEA 1 0.0001
552 ADVERSE REACTION 1 0.0001
553 INSOMNIA 20 0.0001
554 HYPOTENSION 15 0.0001
555 MALIGNANT MELANOMA 1 0.0001
556 FEAR 2 0.0001
557 JAUNDICE 2 0.0001
558 DISTURBANCE IN ATTENTION 4 0.0001
559 THROAT TIGHTNESS 2 0.0001
560 PRODUCT TASTE ABNORMAL 1 0.0001
561 RASH PRURITIC 4 0.0001
562 TACHYPNOEA 1 0.0001
563 DRUG TOXICITY 1 0.0001
564 IMPAIRED GASTRIC EMPTYING 1 0.0001
565 AKATHISIA 1 0.0001
566 DECREASED APPETITE 17 0.0001
567 CORONARY ARTERY OCCLUSION 1 0.0001
568 APPLICATION SITE RASH 1 0.0001
569 MENTAL STATUS CHANGES 2 0.0001
570 ORAL DISCOMFORT 1 0.0001
571 POLLAKIURIA 3 0.0001
572 CARDIO-RESPIRATORY ARREST 3 0.0001
573 APHONIA 1 0.0001
574 RENAL IMPAIRMENT 6 0.0001
575 INJURY 5 0.0001
576 DEVICE OCCLUSION 1 0.0001
577 FEELING ABNORMAL 17 0.0001
578 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
579 URINARY TRACT INFECTION 12 0.0001
580 SUBDURAL HAEMATOMA 1 0.0001
581 HYPERSOMNIA 2 0.0001
582 HYPOACUSIS 3 0.0001
583 DEVICE DISLOCATION 3 0.0001
584 INJECTION SITE HAEMATOMA 1 0.0001
585 LIVER FUNCTION TEST ABNORMAL 2 0.0001
586 SURGERY 4 0.0001
587 LABORATORY TEST ABNORMAL 2 0.0001
588 TACHYCARDIA 6 0.0001
589 PULMONARY OEDEMA 3 0.0001
590 HYPOAESTHESIA ORAL 1 0.0001
591 HIP ARTHROPLASTY 1 0.0001
592 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
593 DEVICE RELATED INFECTION 1 0.0001
594 THYROID DISORDER 1 0.0001
595 ANKLE FRACTURE 1 0.0001
596 VISUAL IMPAIRMENT 8 0.0001
597 NERVOUS SYSTEM DISORDER 2 0.0001
598 BRAIN FOG 1 0.0001
599 CYANOSIS 1 0.0001
600 ANXIETY 18 0.0001
601 PNEUMOTHORAX 1 0.0001
602 COMA 3 0.0001
603 CONTUSION 6 0.0001
604 MUSCULAR WEAKNESS 7 0.0001
605 DEEP VEIN THROMBOSIS 4 0.0001
606 BLOOD CREATININE INCREASED 4 0.0001
607 DYSPEPSIA 6 0.0001
608 STAPHYLOCOCCAL INFECTION 2 0.0001
609 GAIT INABILITY 2 0.0001
610 FACE OEDEMA 1 0.0001
611 ANGER 2 0.0001
612 DIZZINESS 29 0.0001
613 INFLAMMATION 3 0.0001
614 NIGHTMARE 2 0.0001
615 ANAEMIA 11 0.0001
616 OEDEMA PERIPHERAL 7 0.0001
617 NERVOUSNESS 3 0.0001
618 DEVICE USE ISSUE 1 0.0001
619 EOSINOPHILIA 1 0.0001
620 HYPOXIA 2 0.0001
621 SLEEP DISORDER 4 0.0001
622 HYPERTENSION 12 0.0001
623 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
624 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
625 DRUG ERUPTION 1 0.0001
626 ISCHAEMIC STROKE 1 0.0001
627 GALLBLADDER DISORDER 1 0.0001
628 THIRST 1 0.0001
629 DEVICE ISSUE 5 0.0001
630 DRUG EFFECT DECREASED 3 0.0001
631 OEDEMA 3 0.0001
632 PYREXIA 19 0.0001
633 TREATMENT NONCOMPLIANCE 3 0.0001
634 END STAGE RENAL DISEASE 1 0.0001
635 MEDICATION ERROR 3 0.0001
636 HEPATIC STEATOSIS 1 0.0001
637 BACTERIAL INFECTION 1 0.0001
638 MIDDLE INSOMNIA 1 0.0001
639 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
640 HYPONATRAEMIA 3 0.0001
641 PHOTOPHOBIA 1 0.0001
642 INTESTINAL OBSTRUCTION 2 0.0001
643 BLOOD SODIUM DECREASED 1 0.0001
644 UNEVALUABLE EVENT 4 0.0001
645 PULMONARY EMBOLISM 5 0.0001
646 PNEUMONIA 17 0.0001
647 ACUTE KIDNEY INJURY 8 0.0001
648 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
649 EYE IRRITATION 3 0.0001
650 DRUG PRESCRIBING ERROR 1 0.0001
651 ACUTE RESPIRATORY FAILURE 1 0.0001
652 PRESCRIBED OVERDOSE 1 0.0001
653 DYSPHONIA 3 0.0001
654 HAEMATOCRIT DECREASED 1 0.0001
655 SPINAL FRACTURE 1 0.0000
656 ILL-DEFINED DISORDER 3 0.0000
657 PLEURAL EFFUSION 3 0.0000
658 BLINDNESS 2 0.0000
659 NEUTROPHIL COUNT DECREASED 2 0.0000
660 BODY TEMPERATURE INCREASED 1 0.0000
661 PULMONARY HYPERTENSION 1 0.0000
662 PRODUCT DOSE OMISSION ISSUE 14 0.0000
663 RENAL FAILURE ACUTE 2 0.0000
664 SKIN CANCER 1 0.0000
665 PRURITUS GENERALISED 1 0.0000
666 SEPTIC SHOCK 2 0.0000
667 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
668 PERIPHERAL SWELLING 7 0.0000
669 ANGIOEDEMA 2 0.0000
670 TRANSAMINASES INCREASED 1 0.0000
671 SEPSIS 5 0.0000
672 GLOSSODYNIA 1 0.0000
673 HEART RATE IRREGULAR 1 0.0000
674 PRODUCT QUALITY ISSUE 6 0.0000
675 PRODUCT AVAILABILITY ISSUE 1 0.0000
676 SEIZURE 5 0.0000
677 PERICARDIAL EFFUSION 1 0.0000
678 CHEST PAIN 8 0.0000
679 CARDIAC DISORDER 4 0.0000
680 PALPITATIONS 5 0.0000
681 PRODUCT USE ISSUE 8 0.0000
682 DRUG INTOLERANCE 4 0.0000
683 LOCALISED INFECTION 1 0.0000
684 FIBROMYALGIA 1 0.0000
685 NEURALGIA 1 0.0000
686 HEART RATE INCREASED 4 0.0000
687 EPISTAXIS 3 0.0000
688 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
689 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
690 HAEMATEMESIS 1 0.0000
691 DIABETES MELLITUS 3 0.0000
692 THERAPY CESSATION 2 0.0000
693 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
694 UNRESPONSIVE TO STIMULI 1 0.0000
695 HAEMATOMA 1 0.0000
696 DIPLOPIA 1 0.0000
697 SEDATION 1 0.0000
698 JOINT STIFFNESS 1 0.0000
699 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
700 ASTHENIA 14 0.0000
701 PNEUMONITIS 1 0.0000
702 MOOD ALTERED 1 0.0000
703 RESPIRATORY DISTRESS 1 0.0000
704 PROCEDURAL PAIN 1 0.0000
705 FEELING COLD 1 0.0000
706 WOUND 1 0.0000
707 OXYGEN SATURATION DECREASED 2 0.0000
708 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
709 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
710 FLATULENCE 2 0.0000
711 INTENTIONAL DOSE OMISSION 1 0.0000
712 CONVULSION 2 0.0000
713 ANGINA PECTORIS 1 0.0000
714 LETHARGY 2 0.0000
715 INFECTION 5 0.0000
716 PRODUCT STORAGE ERROR 3 0.0000
717 DYSSTASIA 1 0.0000
718 BONE PAIN 2 0.0000
719 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
720 ACUTE MYOCARDIAL INFARCTION 1 0.0000
721 URINARY INCONTINENCE 1 0.0000
722 DEATH 29 0.0000
723 CATARACT 2 0.0000
724 RESPIRATORY DISORDER 1 0.0000
725 HEPATIC FAILURE 1 0.0000
726 APHASIA 1 0.0000
727 LACRIMATION INCREASED 1 0.0000
728 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
729 BLOOD PRESSURE INCREASED 5 0.0000
730 ADVERSE EVENT 3 0.0000
731 OVERDOSE 7 0.0000
732 EMOTIONAL DISORDER 1 0.0000
733 DRUG-INDUCED LIVER INJURY 1 0.0000
734 DRUG INEFFECTIVE 42 0.0000
735 NAUSEA 25 0.0000
736 WEIGHT INCREASED 7 0.0000
737 INTENTIONAL OVERDOSE 2 0.0000
738 AMNESIA 2 0.0000
739 INCORRECT DOSE ADMINISTERED 7 0.0000
740 PAIN IN EXTREMITY 9 0.0000
741 CHOLELITHIASIS 1 0.0000
742 RENAL FAILURE 4 0.0000
743 VISUAL ACUITY REDUCED 1 0.0000
744 EXPIRED PRODUCT ADMINISTERED 1 0.0000
745 VIRAL INFECTION 1 0.0000
746 NEOPLASM MALIGNANT 2 0.0000
747 EYE PRURITUS 1 0.0000
748 MALAISE 13 0.0000
749 FLUSHING 3 0.0000
750 HEPATIC ENZYME INCREASED 2 0.0000
751 CHEST DISCOMFORT 3 0.0000
752 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
753 SINUSITIS 3 0.0000
754 HAEMOGLOBIN DECREASED 3 0.0000
755 GASTRIC DISORDER 1 0.0000
756 ILLNESS 3 0.0000
757 MEMORY IMPAIRMENT 4 0.0000
758 DEVICE USE ERROR 1 0.0000
759 ABDOMINAL DISTENSION 3 0.0000
760 HAEMORRHAGE 3 0.0000
761 MYOCARDIAL INFARCTION 5 0.0000
762 WEIGHT DECREASED 8 0.0000
763 COVID-19 5 0.0000
764 DYSPNOEA 16 0.0000
765 PLATELET COUNT DECREASED 3 0.0000
766 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
767 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
768 PRODUCT ADHESION ISSUE 1 0.0000
769 CEREBRAL HAEMORRHAGE 1 0.0000
770 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
771 C-REACTIVE PROTEIN INCREASED 1 0.0000
772 UNDERDOSE 2 0.0000
773 INJECTION SITE MASS 1 0.0000
774 INFLUENZA 3 0.0000
775 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
776 DISEASE PROGRESSION 3 0.0000
777 CARDIAC FAILURE CONGESTIVE 2 0.0000
778 JOINT SWELLING 3 0.0000
779 DRY MOUTH 2 0.0000
780 COMPLETED SUICIDE 2 0.0000
781 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
782 ABDOMINAL DISCOMFORT 4 0.0000
783 WITHDRAWAL SYNDROME 1 0.0000
784 OSTEOARTHRITIS 1 0.0000
785 RECTAL HAEMORRHAGE 1 0.0000
786 DEVICE LEAKAGE 1 0.0000
787 INTENTIONAL PRODUCT MISUSE 2 0.0000
788 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
789 THROAT IRRITATION 1 0.0000
790 ADVERSE DRUG REACTION 2 0.0000
791 THERAPY NON-RESPONDER 1 0.0000
792 FATIGUE 17 0.0000
793 NEPHROLITHIASIS 1 0.0000
794 TINNITUS 1 0.0000
795 HYPOKALAEMIA 1 0.0000
796 BLOOD CHOLESTEROL INCREASED 1 0.0000
797 COUGH 6 0.0000
798 SWELLING 2 0.0000
799 ARRHYTHMIA 1 0.0000
800 OCULAR HYPERAEMIA 1 0.0000
801 DISEASE RECURRENCE 1 0.0000
802 DRY EYE 1 0.0000
803 LEUKOPENIA 1 0.0000
804 HOSPITALISATION 3 0.0000
805 DEPRESSED MOOD 1 0.0000
806 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
807 PAIN 11 0.0000
808 PANCYTOPENIA 1 0.0000
809 TOXICITY TO VARIOUS AGENTS 3 0.0000
810 EYE PAIN 1 0.0000
811 PRODUCT SUBSTITUTION ISSUE 1 0.0000
812 THERAPEUTIC RESPONSE DECREASED 1 0.0000
813 DISCOMFORT 1 0.0000
814 MUSCLE SPASMS 3 0.0000
815 FEELING HOT 1 0.0000
816 INJECTION SITE ERYTHEMA 2 0.0000
817 BLOOD GLUCOSE INCREASED 3 0.0000
818 DEVICE DIFFICULT TO USE 1 0.0000
819 INJECTION SITE PRURITUS 1 0.0000
820 VOMITING 7 0.0000
821 ERYTHEMA 3 0.0000
822 VISION BLURRED 2 0.0000
823 INJECTION SITE REACTION 1 0.0000
824 HEADACHE 9 0.0000
825 BURNING SENSATION 1 0.0000
826 DEVICE MALFUNCTION 1 0.0000
827 THERAPY INTERRUPTED 1 0.0000
828 SKIN BURNING SENSATION 1 0.0000
829 OFF LABEL USE 12 0.0000
830 BRONCHITIS 1 0.0000
831 DYSGEUSIA 1 0.0000
832 CHRONIC KIDNEY DISEASE 1 0.0000
833 INJECTION SITE SWELLING 1 0.0000
834 PRURITUS 5 0.0000
835 ARTHRITIS 1 0.0000
836 INJECTION SITE BRUISING 1 0.0000
837 THROMBOSIS 1 0.0000
838 CARDIAC ARREST 1 0.0000
839 DRUG DOSE OMISSION 2 0.0000
840 ARTHRALGIA 5 0.0000
841 DRUG ABUSE 1 0.0000
842 GASTROINTESTINAL DISORDER 1 0.0000
843 DIARRHOEA 7 0.0000
844 OROPHARYNGEAL PAIN 1 0.0000
845 BREAST CANCER 1 0.0000
846 NEUROPATHY PERIPHERAL 1 0.0000
847 MIGRAINE 1 0.0000
848 ABDOMINAL PAIN UPPER 2 0.0000
849 ASTHMA 1 0.0000
850 BACK PAIN 2 0.0000
851 ABDOMINAL PAIN 2 0.0000
852 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
853 NEUTROPENIA 1 0.0000
854 RASH 3 0.0000
855 PARAESTHESIA 1 0.0000
856 DRUG DEPENDENCE 1 0.0000
857 URTICARIA 1 0.0000
858 CEREBROVASCULAR ACCIDENT 1 0.0000
859 MYALGIA 1 0.0000
860 HYPERSENSITIVITY 1 0.0000
861 INJECTION SITE PAIN 1 0.0000